Gyan Barik: First-In-Human Trial for Axana Stroke Detection Is Complete
Gyan Barik, Executive Director at Wellumio, shared Wellumio‘s post on LinkedIn, adding:
”Thrilled to share: Wellumio’s FIRST-IN-HUMAN trial for Axana stroke detection tech is COMPLETE at Royal Melbourne Hospital!
A game-changer for faster stroke decisions, huge thanks to participants, families, RMH teams (shoutout Dr James Barker, Amy MacDonald, Profs Geoffrey Donnan and Stephen Davis), and all partners.
Invaluable insights gained.
Phase 2, here we come!”
Quoting Wellumio‘s post:
”We’re very excited to announce the completion of our first-in-human clinical trial at The Royal Melbourne Hospital.
This is a major milestone and a significant step forward for Axana as we work to accelerate stroke detection and decision-making in time-critical settings.
First and foremost, we thank the study participants and their families.
This study would not have been possible without their generosity and willingness to support the advancement of medical technology.
We are also incredibly grateful to the clinicians, investigators, and research teams at RMH, along with all of our collaborators and partners who helped make this possible.
In particular, we’d like to acknowledge Dr James Barker and Amy MacDonald for coordinating the study day to day, and Professors Geoffrey Donnan and Stephen Davis from the Australian Stroke Alliance as the site Principal Investigators.
This trial has generated invaluable insights, and we’re looking forward to returning to the clinic for our Phase 2 trial.”
Stay updated with Hemostasis Today.
-
Feb 27, 2026, 17:05Sumedha Dash: Honored to Successfully Complete the Advanced Certificate in Transfusion Medicine
-
Feb 27, 2026, 17:02Jeff June: Building the Biological Map for Stroke Neuroprotection
-
Feb 27, 2026, 16:55Jorge Monge: Time to Implement Universal Fetal Genotyping for RhD-Negative Pregnant Women
-
Feb 27, 2026, 16:49Ana Codo: When Environmental Particles Disrupt a Fundamental Immune Function
-
Feb 27, 2026, 16:46Wolfgang Miesbach: Gut Feelings About Thrombosis – Microbiota as a Vascular Risk Factor
-
Feb 27, 2026, 16:46Daniel Torrent: A New Path for ‘No-Option’ Patients – TADV vs Standard of Care in CLTI
-
Feb 27, 2026, 16:33Akshat Jain: Live Bone Marrow Aspiration and Biopsy Procedure Workshop
-
Feb 27, 2026, 16:31A Major Milestone for Haemophilia Care in Kenya and the Region – Kenya Haemophilia Association
-
Feb 27, 2026, 16:26Erwin Loh: Centenarian Study Identifies Blood Proteins Linked to Longevity